Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ralf J P, van der Valk"'
Autor:
Erik, Melén, Bright I, Nwaru, Fredrik, Wiklund, Sofie, de Fine Licht, Gunilla, Telg, Ekaterina, Maslova, Ralf J P, van der Valk, Trung N, Tran, Magnus, Ekström, Christer, Janson
Publikováno v:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyREFERENCES. 33(11)
In adults and adolescents with asthma, use of ≥3 short-acting βThis population-based cohort study utilized linked data from the Swedish national healthcare registries involving patients with asthma (18 years) treated in secondary care between 2006
Autor:
Erik Melén, Bright I. Nwaru, Fredrik Wiklund, Sofie de Fine Licht, Gunilla Telg, Ekaterina Maslova, Ralf J. P. van der Valk, Trung N. Tran, Magnus Ekström, Christer Janson
BACKGROUND: In adults and adolescents with asthma, use of ≥3 short-acting β2 -agonist (SABA) canisters/year is associated with increased exacerbation risk. Whether this association is present in younger children remains unknown. In this SABA use I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ae7802ad34973ac2cd75bc94373739
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-492866
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-492866
Autor:
Eric D, Bateman, David B, Price, Hao-Chien, Wang, Adel, Khattab, Patricia, Schonffeldt, Angelina, Catanzariti, Ralf J P, van der Valk, Maarten J H I, Beekman
Publikováno v:
The European respiratory journal. 59(5)
To gain a global perspective on short-acting βSABINA III was a cross-sectional study that employed electronic case report forms at a study visit (in primary or specialist care) to record prescribed medication(s), over-the-counter (OTC) SABA purchase
Autor:
Esther Hafkamp-de Groen, Ralf J P van der Valk, Ashna D Mohangoo, Johannes C van der Wouden, Liesbeth Duijts, Vincent W Jaddoe, Albert Hofman, Harry J de Koning, Johan C de Jongste, Hein Raat
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90982 (2014)
This study aimed to evaluate the effectiveness of systematic assessment of asthma-like symptoms and environmental tobacco smoke (ETS) exposure during regular preventive well-child visits between age 1 and 4 years by well-child professionals.Sixteen w
Externí odkaz:
https://doaj.org/article/1a7cc5ef1cb349138df72ce386a0fce7
Autor:
Njira L Lugogo, Ileen Gilbert, Jennifer K Quint, Ralf J. P. van der Valk, Sofie Arnetorp, Chantal Raherison-Semjen, Santiago Quirce, Maciej Kupczyk, Christer Janson, Erika Penz, Silvia Boarino, Javier Nuevo, Janwillem W. H. Kocks
Publikováno v:
Airway pharmacology and treatment.
Background: Safety concerns around the use of as-needed short-acting β2-agonist (SABA) monotherapy in asthma management warrant evaluation. The SABa use IN Asthma (SABINA) programme captures the current global burden of SABA use. Objective: To exami
Autor:
Karen Coulton, Claudia Cabrera, Chloe I Bloom, Ralf J. P. van der Valk, Jennifer K Quint, Sofie Arnetorp, Cassandra Nan
Introduction Patients with asthma typically increase short-acting β2-agonists (SABA) use with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse outcomes. We evaluated, in a large population cohort, an association between SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640590ade1ab31ee94d2a516dd2a8a18
http://hdl.handle.net/10044/1/81432
http://hdl.handle.net/10044/1/81432
Autor:
Chloe I, Bloom, Claudia, Cabrera, Sofie, Arnetorp, Karen, Coulton, Cassandra, Nan, Ralf J P, van der Valk, Jennifer K, Quint
Publikováno v:
Advances in therapy. 37(10)
Patients with asthma typically increase short-acting βAs part of the SABINA (SABA use IN Asthma) global program, we conducted a retrospective longitudinal observational study (SABINA I) using UK primary care electronic healthcare records (Clinical P
Autor:
Maarten J.H.I. Beekman, Ralf J. P. van der Valk, Eric D. Bateman, David Price, Hao-Chien Wang, Patricia Schonffeldt, Adel Khattab, Angelina Catanzariti
Publikováno v:
European Respiratory Journal. 59:2101402
BackgroundTo gain a global perspective on short-acting β2-agonist (SABA) prescriptions and associated asthma-related clinical outcomes in patients with asthma, we assessed primary health data across 24 countries in five continents.MethodsSABINA III
Autor:
Dave Singh, Robert A. Wise, David Halpin, MeiLan K. Han, Mark T. Dransfield, Peter Lange, C.E. Jones, Gerard J. Criner, David A. Lipson, Emma C.Y. Hilton, Sally Kilbride, Fernando J. Martinez, Ralf J. P. van der Valk
Publikováno v:
Chest. 154:729A-731A
Autor:
Claudia S, Cabrera, Cassandra, Nan, Niklas, Lindarck, Maarten J H I, Beekman, Sofie, Arnetorp, Ralf J P, van der Valk
Publikováno v:
The European respiratory journal. 55(2)